Results 111 to 120 of about 16,072,038 (292)

Exercise training and the apolipoprotein A‑I to HDL‑cholesterol ratio.

open access: yes, 2009
[[abstract]]Low concentrations of high-density lipoprotein cholesterol (HDL-C) are a recognized risk factor for atherosclerotic cardiovascular disease. Exercise is often recommended to increase HDL-C, but the effect of exercise training on HDL levels and
Joseph M Zmuda;Susan M Yurgalevitch;Mary M Flynn;Linda L Bausserman;Ann Saratelli;Donna J Spannaus-Martin;Peter N Herbert;Paul D Thompson
core  

Exploring the Roles of Tuna‐Associated Acinetobacter sp. YFT067: Implications for Host Health and Metabolism

open access: yesAnimal Research and One Health, EarlyView.
This study firstly isolated a tuna‐derived gut probiotic Acinetobacter seifertii YFT067. Dietary administration of YFT067 played significant roles in promoting growth performance, SCFAs production, lipid absorption, and metabolism of the host, indicating YFT067 as a promising probiotic candidate for enhancing tuna aquaculture productivity through ...
Ying Zou   +4 more
wiley   +1 more source

Systemic Review to Explore the Effect of Dyslipidaemia and Metabolic Function in Coronary Heart Disease with Type 2 Diabetes Mellitus: In Tertiary Care Center

open access: yesJournal of Pharmacy and Bioallied Sciences
Metabolic dyslipidemia (high triglyceride) and low high-density lipoprotein cholesterol (HDL-C) are highly prevalent in type 2 diabetes mellitus (T2DM).
Akansha Singh   +2 more
doaj   +1 more source

Fasting and Refeeding Mediated Phospholipid Remodeling Plays an Important Role in Improving Meat Quality of Aged Laying Hens

open access: yesAnimal Research and One Health, EarlyView.
ABSTRACT This study explored fasting‐induced physiological remodeling effects on meat quality in aged laying hens. Fasting for 15 days (F15) significantly reduced abdominal fat, intermuscular fat width, subcutaneous fat thickness, and liver index versus pre‐fasting (F0) (p < 0.05), which recovered post‐refeeding.
Xiaoran Zhang   +8 more
wiley   +1 more source

HDL therapy for the treatment of cardiovascular diseases

open access: yes, 2009
High-density lipoprotein (HDL) therapy is an emerging area of therapeutic development in the cardiovascular field, aimed at supplementing and improving the vascular benefit exerted by current treatments.
C. Parolini, M. Marchesi, G. Chiesa
core   +1 more source

Unveiling Endotypes in Systemic Lupus Erythematosus Through Multiomic Analysis: Insights Into Cardiovascular and Renal Complications

open access: yesArthritis &Rheumatology, EarlyView.
Objective Systemic lupus erythematosus (SLE) shows clinical and molecular heterogeneity, and cardiovascular (CV) complications and lupus nephritis (LN) remain leading causes of morbidity and mortality. This study investigated whether omic profiling can reveal molecular endotypes linked to these outcomes.
Tomás Cerdó   +84 more
wiley   +1 more source

HDL and endothelial protection : examining evidence from HDL inherited disorders

open access: yes, 2013
Epidemiological studies have clearly demonstrated that plasma concentrations of HDL cholesterol are strongly and inversely associated with cardiovascular risk.
L. Calabresi   +3 more
core   +1 more source

Emergent Biomarkers of Residual Cardiovascular Risk in Patients with Low HDL-c and/or High Triglycerides and Average LDL-c Concentrations: Focus on HDL Subpopulations, Oxidized LDL, Adiponectin, and Uric Acid [PDF]

open access: yes, 2013
This study intended to determine the impact of HDL-c and/or TGs levels on patients with average LDL-c concentration, focusing on lipidic, oxidative, inflammatory, and angiogenic profiles.
Rui Pinto   +20 more
core   +1 more source

Effects of Oil Tea on Obesity and Dyslipidemia: A Cross-Sectional Study in China

open access: yesDiabetes, Metabolic Syndrome and Obesity, 2021
Jiansheng Cai,1,2,* Shuzhen Liu,1,* You Li,3,* Qiumei Liu,1 Min Xu,1 Chunbao Mo,3 Tingyu Mai,3 Xia Xu,1 Xu Tang,1 Quanhui Chen,1 Chuntao Nong,1 Huaxiang Lu,1,3 Haoyu He,1,4 Jiexia Tang,5 Junling Zhang,1 Chunmei Wei,1 Dechan Tan,3 Jian Qin,1 ...
Cai J   +18 more
doaj  

Ixekizumab With Tirzepatide Achieved Greater Disease Control Than Ixekizumab Alone in Adults With Psoriatic Arthritis and Overweight or Obesity: Results From a Randomized Clinical Trial

open access: yesArthritis &Rheumatology, EarlyView.
Objective Overweight or obesity is prevalent in 72% to 82% of individuals with psoriatic arthritis (PsA). We assessed the efficacy and safety of ixekizumab (IXE) concomitantly administered with tirzepatide (TZP) compared with IXE alone in adult participants with active PsA and overweight with at least one weight‐related comorbidity or obesity.
Joseph F. Merola   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy